針なし注射システムの世界市場規模調査＆予測：製品別、動力源別、タイプ別、使用性別、送達部位別、用途別、エンドユーザー別、地域別分析、2023-2030年

針なし注射システムの世界市場は、2022年に約1億5,600万米ドルと評価され、予測期間2023-2030年には20％以上の健全な成長率で成長すると予測されています。

針なし注射システムは、皮膚に穴を開ける従来の注射針を使用せずに、液体製剤、薬剤、ワクチンを患者に送達するために利用されます。これらのシステムの需要は、ワクチンに対する免疫反応を高め、注射針に関連するリスクを軽減し、ヘルスケア費用を削減する能力により、近年大幅に増加しています。市場成長の原動力となっているのは、患者数の増加と治療の促進、研究開発費の増加、糖尿病有病率の上昇といった主な要因です。

薬剤は、注射針を使用せずに、可能な限り簡便かつ無痛で体内に投与されることを目的としています。針なし注射システムは、様々な症状を治療するための薬物送達に採用されています。骨粗しょう症や糖尿病などの慢性疾患の有病率の増加により、針なし注射システム市場の価値は予測期間中に上昇すると予測されています。例えば、米国では2022年に3,370万人以上の入院が記録されました。近年、病院数は減少しているもの、同国では高齢者人口が増加しています。また、過去1年間に1回以上の入院を報告した人の割合は、男性が4.8％であったのに対し、女性は約7.2％でした。さらに、65歳以上の16.6％が過去1年間に入院を経験しているのに対し、18歳から44歳では6.6％に過ぎないです。米国の平均入院期間は5.7日です。しかし、熟練した専門家の不足と静脈内投与用の針なし注射システムの使用制限が、2023～2030年の予測期間を通じて市場の成長を阻害しています。

針なし注射システムの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、堅牢なヘルスケアインフラ、主要市場プレイヤーの顕著な存在感、慢性疾患の症例の増加、地域内の研究努力の急増に支えられて、世界の針なし注射システム市場をリードしています。

一方、アジア太平洋地域は2023年から2030年にかけて最も急成長する地域と予想されています。この成長の背景には、認知度向上を目的とした政府の取り組みの活発化、研究活動の拡大、未開拓の広大な市場へのアクセス、大規模な人口基盤、地域全体における質の高いヘルスケアサービスに対する需要の高まりがあります。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 針なし注射システムの世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 業界の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 針なし注射システムの世界市場力学

• 針なし注射システム市場の影響分析（2020-2030年）
  • 市場促進要因
    • 患者数の増加と治療の促進
    • 研究開発費の増加
    • 糖尿病患者の増加
  • 市場の課題
    • 熟練した専門家の不足
    • 静脈内投与における針なし注射システムの使用制限
  • 市場機会
    • 無痛ドラッグデリバリーへの需要の増加
    • ワクチン接種プログラムの拡大

第4章 針なし注射システムの世界市場産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターのファイブフォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 針なし注射システムの世界市場：製品別

• 市場スナップショット
• 針なし注射システムの世界市場：製品別、実績 - ポテンシャル分析
• 針なし注射システムの世界市場：製品別推定・予測2020-2030年
• 針なし注射システム市場、サブセグメント別分析
  • 充填可能
  • プレフィルド

第6章 針なし注射システムの世界市場：動力源別

• 市場スナップショット
• 針なし注射システムの世界市場：動力源別、実績 - ポテンシャル分析
• 針なし注射システムの世界市場：動力源別推定・予測2020-2030年
• ニードルフリー注射システム市場、サブセグメント分析
  • スプリング式インジェクターシステム
  • ガス推進/空気強制インジェクターシステム

第7章 ニードルフリー噴射システムの世界市場：タイプ別

• 市場スナップショット
• ニードルフリー噴射システムの世界市場：タイプ別、実績 - ポテンシャル分析
• ニードルフリー噴射システムの世界市場タイプ別推定・予測2020-2030年
• 針なし注射システム市場、サブセグメント別分析
  • 液体ベース
  • 射出/蓄積注射
  • 粉末ベース

第8章 針なし注射システムの世界市場：使用性別

• 市場スナップショット
• 針なし注射システムの世界市場：使用性・性能別-潜在能力分析
• 針なし注射システムの世界市場：ユーザビリティ別推定・予測2020-2030年
• 針なし注射システム市場、サブセグメント別分析
  • 使い捨て
  • 再利用可能

第9章 針なし注射システムの世界市場：送達部位別

• 市場スナップショット
• 針なし注射システムの世界市場：送達部位別、実績 - ポテンシャル分析
• 針なし注射システムの世界市場：投与部位別推定・予測2020-2030年
• 針なし注射システム市場、サブセグメント別分析
  • 皮下注射器
  • 筋肉内注射器
  • 皮内注射器

第10章 針なし注射システムの世界市場：用途別

• 市場スナップショット
• 針なし注射システムの世界市場：用途別、実績 - ポテンシャル分析
• 針なし注射システムの世界市場：用途別推定・予測2020-2030年
• 針なし注射システム市場、サブセグメント分析
  • ワクチンデリバリー
  • インスリンデリバリー
  • 疼痛管理
  • その他

第11章 針なし注射システムの世界市場：エンドユーザー別

• 市場スナップショット
• 針なし注射システムの世界市場：エンドユーザー別、実績 - ポテンシャル分析
• 針なし注射システムの世界市場：エンドユーザー別推定・予測2020-2030年
• 針なし注射システム市場、サブセグメント分析
  • 病院と診療所
  • 在宅医療現場
  • 研究機関
  • その他

第12章 針なし注射システムの世界市場、地域分析

• 主要国
• 主な新興国
• 針なし注射システム市場、地域別市場スナップショット
• 北米
  • 米国
    • 製品の推定・予測、2020-2030年
    • 動力源別の推定・予測、2020-2030年
    • タイプの推定・予測、2020-2030年
    • ユーザビリティの推定・予測、2020-2030年
    • 納入場所別の推定・予測、2020-2030年
    • アプリケーションの推定・予測、2020-2030年
    • エンドユーザーの推定・予測、2020-2030年
  • カナダ
• 欧州の針なし注射システム市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋針なし注射システム市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの針なし注射システム市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第13章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • NuGen Medical Devices (Canada
    • 主要情報
    • 概要
    • 財務（データの入手が可能な場合のみ）
    • 製品概要
    • 最近の動向
  • PharmaJet (U.S.)
  • Portal Instruments (U.S.)
  • Medical International Technology, Inc (U.S.)
  • Crossject SA (U.S.)
  • Antares Pharma (U.S.)
  • M (U.S.)
  • Injex Pharma AG (Germany)
  • NovaXS Biotech (U.S.)
  • INVIO Pharmaceutical Inc. (U.S.)

第14章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1.Global Needle-Free Injection Systems Market, report scope
• TABLE 2.Global Needle-Free Injection Systems Market estimates & forecasts by Region 2020-2030 (USD Million)
• TABLE 3.Global Needle-Free Injection Systems Market estimates & forecasts by Product 2020-2030 (USD Million)
• TABLE 4.Global Needle-Free Injection Systems Market estimates & forecasts by Source of Power 2020-2030 (USD Million)
• TABLE 5.Global Needle-Free Injection Systems Market estimates & forecasts by Type 2020-2030 (USD Million)
• TABLE 6.Global Needle-Free Injection Systems Market estimates & forecasts by Usability 2020-2030 (USD Million)
• TABLE 7.Global Needle-Free Injection Systems Market estimates & forecasts by Site of Delivery 2020-2030 (USD Million)
• TABLE 8.Global Needle-Free Injection Systems Market estimates & forecasts by Application 2020-2030 (USD Million)
• TABLE 9.Global Needle-Free Injection Systems Market estimates & forecasts by End-user 2020-2030 (USD Million)
• TABLE 10.
• TABLE 11.Global Needle-Free Injection Systems Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 12.Global Needle-Free Injection Systems Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 13.Global Needle-Free Injection Systems Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 14.Global Needle-Free Injection Systems Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 15.Global Needle-Free Injection Systems Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 16.Global Needle-Free Injection Systems Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 17.Global Needle-Free Injection Systems Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 18.Global Needle-Free Injection Systems Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 19.Global Needle-Free Injection Systems Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 20.Global Needle-Free Injection Systems Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 21.U.S. Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 22.U.S. Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 23.U.S. Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 24.Canada Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 25.Canada Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 26.Canada Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 27.UK Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 28.UK Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 29.UK Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 30.Germany Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 31.Germany Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 32.Germany Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 33.France Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 34.France Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 35.France Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 36.Italy Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 37.Italy Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 38.Italy Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 39.Spain Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 40.Spain Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 41.Spain Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 42.RoE Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 43.RoE Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 44.RoE Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 45.China Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 46.China Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 47.China Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 48.India Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 49.India Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 50.India Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 51.Japan Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 52.Japan Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 53.Japan Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 54.South Korea Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 55.South Korea Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 56.South Korea Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 57.Australia Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 58.Australia Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 59.Australia Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 60.RoAPAC Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 61.RoAPAC Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 62.RoAPAC Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 63.Brazil Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 64.Brazil Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 65.Brazil Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 66.Mexico Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 67.Mexico Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 68.Mexico Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 69.RoLA Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 70.RoLA Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 71.RoLA Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 72.Saudi Arabia Needle-Free Injection Systems Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 73.South Africa Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 74.RoMEA Needle-Free Injection Systems Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 75.List of secondary sources, used in the study of global Needle-Free Injection Systems Market
• TABLE 76.List of primary sources, used in the study of global Needle-Free Injection Systems Market
• TABLE 77.Years considered for the study
• TABLE 78.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1.Global Needle-Free Injection Systems Market, research methodology
• FIG 2.Global Needle-Free Injection Systems Market, Market estimation techniques
• FIG 3.Global Market size estimates & forecast methods
• FIG 4.Global Needle-Free Injection Systems Market, key trends 2022
• FIG 5.Global Needle-Free Injection Systems Market, growth prospects 2023-2030
• FIG 6.Global Needle-Free Injection Systems Market, porters 5 force model
• FIG 7.Global Needle-Free Injection Systems Market, pest analysis
• FIG 8.Global Needle-Free Injection Systems Market, value chain analysis
• FIG 9.Global Needle-Free Injection Systems Market by segment, 2020 & 2030 (USD Million)
• FIG 10.Global Needle-Free Injection Systems Market by segment, 2020 & 2030 (USD Million)
• FIG 11.Global Needle-Free Injection Systems Market by segment, 2020 & 2030 (USD Million)
• FIG 12.Global Needle-Free Injection Systems Market by segment, 2020 & 2030 (USD Million)
• FIG 13.Global Needle-Free Injection Systems Market by segment, 2020 & 2030 (USD Million)
• FIG 14.Global Needle-Free Injection Systems Market, regional snapshot 2020 & 2030
• FIG 15.North America Needle-Free Injection Systems Market 2020 & 2030 (USD Million)
• FIG 16.Europe Needle-Free Injection Systems Market 2020 & 2030 (USD Million)
• FIG 17.Asia pacific Needle-Free Injection Systems Market 2020 & 2030 (USD Million)
• FIG 18.Latin America Needle-Free Injection Systems Market 2020 & 2030 (USD Million)
• FIG 19.Middle East & Africa Needle-Free Injection Systems Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Needle-Free Injection Systems Market is valued approximately USD 156 million in 2022 and is anticipated to grow with a healthy growth rate of more than 20% over the forecast period 2023-2030. Needle-free injection systems are utilized for delivering liquid formulations, medications, and vaccines to patients without the use of traditional needles that pierce the skin. The demand for these systems has significantly risen in recent years due to their ability to enhance immune responses to vaccines, mitigate needle-related risks, and lower healthcare expenses. The market growth is driven by key factors such as growing Prevalence of Patients and Promote Treatment, rising expenditure for research and development, and rise in prevalence of diabetes.

Drugs are intended to be administered into the body most conveniently and painlessly possible, without the use of injection needles. Needle-free injection systems are employed for delivering medications to treat various conditions. It is projected that the value of the needle-free injection system market will rise over the forecasted period, driven by the growing prevalence of chronic diseases such as osteoporosis and diabetes. For instance, in 2022, the United States recorded over 33.7 million hospital admissions. Despite a decline in the number of hospitals in recent years, the country is witnessing a rise in its elderly population. As anticipated, the elderly constitute the largest demographic among hospital admissions in the U.S. Also, Hospital stays are more prevalent among females than males, with approximately 7.2 percent of females reporting one or more hospital stays in the past year, compared to 4.8 percent of males. Additionally, 16.6 percent of individuals aged 65 years and older experienced hospitalization in the past year, in contrast to only 6.6 percent of those aged 18 to 44 years. On average, a hospital stay in the United States lasts for 5.7 days. However, the lack of skilled professionals and restricted use of needle-free injection systems for intravenous administration stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Needle-Free Injection Systems Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is leading the Global Needle-Free Injection Systems Market, supported by robust healthcare infrastructure, the prominent presence of key market players, escalating cases of chronic diseases, and a surge in research endeavors within the region.

Meanwhile, the Asia-Pacific region is expected to be the fastest growing region from 2023 to 2030. This growth can be attributed to increased government initiatives aimed at raising awareness, expanding research activities, access to vast untapped markets, a large population base, and growing demand for quality healthcare services across the region.

Major market player included in this report are:

• NuGen Medical Devices (Canada)
• PharmaJet (U.S.)
• Portal Instruments (U.S.)
• Medical International Technology, Inc (U.S.)
• Crossject SA (U.S.)
• Antares Pharma (U.S.)
• 3M (U.S.)
• Injex Pharma AG (Germany)
• NovaXS Biotech (U.S.)
• INVIO Pharmaceutical Inc. (U.S.)

Recent Developments in the Market:

• In October 2022, Science - Link Trading, a company dedicated to facilitating the commercialization of emerging disruptive technologies, entered into a distributorship agreement with NuGen Medical Devices Inc., a trailblazer in needle-free medicine delivery. The agreement outlines the purchase of 34,000 InsuJet devices over a span of five years, along with additional accessories.
• In June 2022, NovaXS Biotech unveiled the latest prototype of its innovative smart medical device for needle-free injectable therapy. Named Telosis, this patent-pending device from NovaXS delivers medication through a narrow stream in just 0.3 seconds, eliminating the need for needles. Furthermore, Telosis evaluates injection data to enable informed medical decisions.

Global Needle-Free Injection Systems Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product, Source of Power, Type, Usability, Site of Delivery, Application, End-user, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Fillable
• Prefilled

By Source of Power:

• Spring-based Injector Systems
• Gas Propelled/Air Forced Injector Systems

By Type:

• Liquid-based
• Projectile/Depot-based
• Powder-based

By Usability:

• Disposable
• Reusable

By Site of Delivery:

• Subcutaneous Injectors
• Intramuscular Injectors
• Intradermal Injectors

By Application:

• Vaccine Delivery
• Insulin Delivery
• Pain Management
• Others

By End User:

• Hospitals & Clinics
• Home Care Settings
• Research Laboratories
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1.Needle-Free Injection Systems Market, by Region, 2020-2030 (USD Million)
  • 1.2.2.Needle-Free Injection Systems Market, by Product, 2020-2030 (USD Million)
  • 1.2.3.Needle-Free Injection Systems Market, by Source of Power, 2020-2030 (USD Million)
  • 1.2.4.Needle-Free Injection Systems Market, by Type, 2020-2030 (USD Million)
  • 1.2.5.Needle-Free Injection Systems Market, by Usability, 2020-2030 (USD Million)
  • 1.2.6.Needle-Free Injection Systems Market, by Site of Delivery, 2020-2030 (USD Million)
  • 1.2.7.Needle-Free Injection Systems Market, by Application, 2020-2030 (USD Million)
  • 1.2.8.Needle-Free Injection Systems Market, by End-user, 2020-2030 (USD Million)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Needle-Free Injection Systems Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Needle-Free Injection Systems Market Dynamics

• 3.1.Needle-Free Injection Systems Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Growing Prevalence of Patients and Promote Treatment
    • 3.1.1.2.Rising expenditure for research and development
    • 3.1.1.3.Rise in prevalence of diabetes
  • 3.1.2.Market Challenges
    • 3.1.2.1.Lack of skilled professionals
    • 3.1.2.2.Restricted use of needle-free injection systems for intravenous administration
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Increasing Demand for Painless Drug Delivery
    • 3.1.3.2.Expansion of Vaccination Programs

Chapter 4.Global Needle-Free Injection Systems Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Needle-Free Injection Systems Market, by Product

• 5.1.Market Snapshot
• 5.2.Global Needle-Free Injection Systems Market by Product, Performance - Potential Analysis
• 5.3.Global Needle-Free Injection Systems Market Estimates & Forecasts by Product 2020-2030 (USD Million)
• 5.4.Needle-Free Injection Systems Market, Sub Segment Analysis
  • 5.4.1.Fillable
  • 5.4.2.Prefilled

Chapter 6.Global Needle-Free Injection Systems Market, by Source of Power

• 6.1.Market Snapshot
• 6.2.Global Needle-Free Injection Systems Market by Source of Power, Performance - Potential Analysis
• 6.3.Global Needle-Free Injection Systems Market Estimates & Forecasts by Source of Power 2020-2030 (USD Million)
• 6.4.Needle-Free Injection Systems Market, Sub Segment Analysis
  • 6.4.1.Spring-based Injector Systems
  • 6.4.2.Gas Propelled/Air Forced Injector Systems

Chapter 7.Global Needle-Free Injection Systems Market, by Type

• 7.1.Market Snapshot
• 7.2.Global Needle-Free Injection Systems Market by Type, Performance - Potential Analysis
• 7.3.Global Needle-Free Injection Systems Market Estimates & Forecasts by Type 2020-2030 (USD Million)
• 7.4.Needle-Free Injection Systems Market, Sub Segment Analysis
  • 7.4.1.Liquid-based
  • 7.4.2.Projectile/Depot-based
  • 7.4.3.Powder-based

Chapter 8.Global Needle-Free Injection Systems Market, by Usability

• 8.1.Market Snapshot
• 8.2.Global Needle-Free Injection Systems Market by Usability, Performance - Potential Analysis
• 8.3.Global Needle-Free Injection Systems Market Estimates & Forecasts by Usability 2020-2030 (USD Million)
• 8.4.Needle-Free Injection Systems Market, Sub Segment Analysis
  • 8.4.1.Disposable
  • 8.4.2.Reusable

Chapter 9.Global Needle-Free Injection Systems Market, by Site of Delivery

• 9.1.Market Snapshot
• 9.2.Global Needle-Free Injection Systems Market by Site of Delivery, Performance - Potential Analysis
• 9.3.Global Needle-Free Injection Systems Market Estimates & Forecasts by Site of Delivery 2020-2030 (USD Million)
• 9.4.Needle-Free Injection Systems Market, Sub Segment Analysis
  • 9.4.1. Subcutaneous Injectors
  • 9.4.2.Intramuscular Injectors
  • 9.4.3.Intradermal Injectors

Chapter 10.Global Needle-Free Injection Systems Market, by Application

• 10.1.Market Snapshot
• 10.2.Global Needle-Free Injection Systems Market by Application, Performance - Potential Analysis
• 10.3.Global Needle-Free Injection Systems Market Estimates & Forecasts by Application 2020-2030 (USD Million)
• 10.4.Needle-Free Injection Systems Market, Sub Segment Analysis
  • 10.4.1.Vaccine Delivery
  • 10.4.2.Insulin Delivery
  • 10.4.3.Pain Management
  • 10.4.4.Others

Chapter 11.Global Needle-Free Injection Systems Market, by End-user

• 11.1.Market Snapshot
• 11.2.Global Needle-Free Injection Systems Market by End-user, Performance - Potential Analysis
• 11.3.Global Needle-Free Injection Systems Market Estimates & Forecasts by End-user 2020-2030 (USD Million)
• 11.4.Needle-Free Injection Systems Market, Sub Segment Analysis
  • 11.4.1.Hospitals & Clinics
  • 11.4.2.Home Care Settings
  • 11.4.3.Research Laboratories
  • 11.4.4.Others

Chapter 12.Global Needle-Free Injection Systems Market, Regional Analysis

• 12.1.Top Leading Countries
• 12.2.Top Emerging Countries
• 12.3.Needle-Free Injection Systems Market, Regional Market Snapshot
• 12.4.North America Needle-Free Injection Systems Market
  • 12.4.1.U.S. Needle-Free Injection Systems Market
    • 12.4.1.1.Product breakdown estimates & forecasts, 2020-2030
    • 12.4.1.2.Source of Power breakdown estimates & forecasts, 2020-2030
    • 12.4.1.3.Type breakdown estimates & forecasts, 2020-2030
    • 12.4.1.4.Usability breakdown estimates & forecasts, 2020-2030
    • 12.4.1.5.Site of Delivery breakdown estimates & forecasts, 2020-2030
    • 12.4.1.6.Application breakdown estimates & forecasts, 2020-2030
    • 12.4.1.7.End-user breakdown estimates & forecasts, 2020-2030
  • 12.4.2.Canada Needle-Free Injection Systems Market
• 12.5.Europe Needle-Free Injection Systems Market Snapshot
  • 12.5.1.U.K. Needle-Free Injection Systems Market
  • 12.5.2.Germany Needle-Free Injection Systems Market
  • 12.5.3.France Needle-Free Injection Systems Market
  • 12.5.4.Spain Needle-Free Injection Systems Market
  • 12.5.5.Italy Needle-Free Injection Systems Market
  • 12.5.6.Rest of Europe Needle-Free Injection Systems Market
• 12.6.Asia-Pacific Needle-Free Injection Systems Market Snapshot
  • 12.6.1.China Needle-Free Injection Systems Market
  • 12.6.2.India Needle-Free Injection Systems Market
  • 12.6.3.Japan Needle-Free Injection Systems Market
  • 12.6.4.Australia Needle-Free Injection Systems Market
  • 12.6.5.South Korea Needle-Free Injection Systems Market
  • 12.6.6.Rest of Asia Pacific Needle-Free Injection Systems Market
• 12.7.Latin America Needle-Free Injection Systems Market Snapshot
  • 12.7.1.Brazil Needle-Free Injection Systems Market
  • 12.7.2.Mexico Needle-Free Injection Systems Market
• 12.8.Middle East & Africa Needle-Free Injection Systems Market
  • 12.8.1.Saudi Arabia Needle-Free Injection Systems Market
  • 12.8.2.South Africa Needle-Free Injection Systems Market
  • 12.8.3.Rest of Middle East & Africa Needle-Free Injection Systems Market

Chapter 13.Competitive Intelligence

• 13.1.Key Company SWOT Analysis
• 13.2.Top Market Strategies
• 13.3.Company Profiles
  • 13.3.1. NuGen Medical Devices (Canada)
    • 13.3.1.1.Key Information
    • 13.3.1.2.Overview
    • 13.3.1.3.Financial (Subject to Data Availability)
    • 13.3.1.4.Product Summary
    • 13.3.1.5.Recent Developments
  • 13.3.2. PharmaJet (U.S.)
  • 13.3.3.Portal Instruments (U.S.)
  • 13.3.4.Medical International Technology, Inc (U.S.)
  • 13.3.5.Crossject SA (U.S.)
  • 13.3.6.Antares Pharma (U.S.)
  • 13.3.7.3M (U.S.)
  • 13.3.8.Injex Pharma AG (Germany)
  • 13.3.9.NovaXS Biotech (U.S.)
  • 13.3.10.INVIO Pharmaceutical Inc. (U.S.)

Chapter 14.Research Process

• 14.1.Research Process
  • 14.1.1.Data Mining
  • 14.1.2.Analysis
  • 14.1.3.Market Estimation
  • 14.1.4.Validation
  • 14.1.5.Publishing
• 14.2.Research Attributes
• 14.3.Research Assumption